Table 2. Correlation between gene-set PROX1 and α-SMA expression and patients' clinicopathological characteristics.

	PROX1 (+) α-SMA (+)4	PROX1 (+) α-SMA (−)3	PROX1 (−) α-SMA (−)2	PROX1 (−) α-SMA (−)1	P-value
Patient number (n)	116	0	14	34
Serosal invasion					<0.001
Positive	111		12	8
Negative	5		2	26
Lymphatic invasion					0.006
Positive	65		5	9
Negative	51		9	25
Venous invasion					0.217
Positive	53		5	10
Negative	63		9	24
Lymph node metastasis					<0.001
Positive	69		7	2
Negative	47		7	32
Distant metastasis					0.054
Positive	13		0	0
Negative	113		14	34
Stage					<0.001
I	0		2	25
II	45		5	7
III	58		7	2
IV	13		0	0